[S18★☆] Recent trends and future perspectives for non-clinical pharmacokinetics and safety evaluation of therapeutic monoclonal antibodies —at the dawn of a new era

1:13 PM - 1:36 PM JST(4:13 AM - 4:36 AM UTC)

[S18-1] Global trends in nonclinical safety assessment and perspectives for utilizing new approach methods (NAMs) in antibody drug evaluation

○Yoko Hirabayashi¹ (1. National Institute of Health Sciences)